Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393:1745–59.
2. Yao Q, Wu X, Tao C, et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 2023;8:56.
3. Quicke JG, Conaghan PG, Corp N, Peat G. Osteoarthritis year in review 2021: epidemiology & therapy. Osteoarthritis Cartilage. 2022;30:196–206.
4. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5:e508–e522.
5. Fu W, Vasylyev D, Bi Y, et al. Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. Nature. 2024;625:557–565.